Document:

AMENDMENT
      NO.1 TO THE

    2007
      INCENTIVE PLAN 

    OF

    PURPLE
      BEVERAGE COMPANY, INC.

     

    This
      Amendment No. 1 (the “Amendment”) to the 2007 Incentive Plan (the “Plan”) of
      Purple Beverage Company, Inc. (the “Company”) is made effective as of the
      15th
      day of
      September, 2008. Capitalized terms not otherwise defined herein shall have
      the
      meaning assigned to such terms in the Plan.

     

    The
      Plan
      is hereby amended by deleting the text of Section 4.3(c) thereof in its entirety
      and replacing it with the following:

     

    “Restricted
      Shares or Restricted Share Units:
      The
      maximum aggregate grant with respect to Awards of Restricted Shares or
      Restricted Share Units in any one Plan Year to any one Participant shall be
      2,000,000 Shares.” 

     

    Except
      as
      modified and amended hereby, the Plan remains in full force and effect with
      no
      further amendment or modification.

    

     

     

    

    

    IN
      WITNESS WHEREOF, Purple Beverage Company, Inc. has caused its duly authorized
      officer to execute this instrument of amendment this 15th
      day of
      September, 2008.

     

    
      	 	 	 
	 	PURPLE BEVERAGE COMPANY, INC.
	 
 	 
 	 
 
	 	By:  	/s
              Theodore FarnsworthCONSENT
      LETTER

    

    I,
      Theodore Farnsworth, hereby waive all rights to receive 2,000,000 shares of
      common stock, par value $0.001 per share, of Purple Beverage Company, Inc.
      granted pursuant to options exercisable under the 2007 Incentive Plan (the
      “Plan”) of Venture Beverage Company, which options are hereby cancelled and
      shall be deemed to be null and void and have no further effect and shall be
      available for re-issuance under the Plan. 

    

    

    Dated:
      September 15, 2008

     

    

    /s/
      Theodore
      Farnsworth               

    Name:
      Theodore FarnsworthEXHIBIT
      10.1

    

    HEALTH
      SYSTEMS SOLUTIONS, INC.

    a
      Nevada corporation

    

    PREFERRED
      STOCK PURCHASE AGREEMENT

    

    THIS
      PREFERRED STOCK PURCHASE AGREEMENT,
      dated
      as of 11th
      day of
      September, 2008 (the “Agreement”),
      is
      entered into by and between HEALTH SYSTEMS SOLUTIONS, INC., a Nevada corporation
      (the “Company”),
      and
      STANFORD INTERNATIONAL BANK LTD., an Antiguan banking corporation (the
“Purchaser”).

    

    W
      I T N E S S E T H:

    

    WHEREAS,
      the
      Company and the Purchaser are executing and delivering this Agreement in
      reliance upon the exemptions from registration provided by Regulation D
      (“Regulation
      D”)
      promulgated by the Securities and Exchange Commission (the “Commission”)
      under
      the Securities Act of 1933, as amended (the “Securities
      Act”),
      and/or Section 4(2) of the Securities Act; and

    

    WHEREAS,
      upon
      the terms and conditions of this Agreement, the Purchaser has agreed to
      purchase, and the Company wishes to issue and sell, for an aggregate purchase
      price of up to $5,000,000 (i) up to 833,334 shares of the Company’s Series E
      Convertible Preferred Stock, $0.001 par value per share (the “Series
      E Preferred Stock”),
      the
      terms of which are as set forth in the Certificate of Designation of Series
      E
      Convertible Preferred Stock attached hereto as Exhibit A (the “Series
      E Certificate of Designation”)
      and
      (ii) warrants (the “Warrants”)
      to
      purchase an aggregate of up to 833,334 shares of the Company’s common stock,
      $.001 par value per share (the “Common
      Stock”);
      and

    

    WHEREAS,
      the
      Series E Preferred Stock shall be convertible into shares of Common Stock
      pursuant to the terms set forth in the Series E Certificate of Designation,
      and
      the Warrants may be exercised for the purchase of Common Stock, pursuant to
      the
      terms set forth therein; and

    

    NOW,
      THEREFORE,
      in
      consideration of the premises and the mutual covenants contained herein and
      other good and valuable consideration, the receipt and sufficiency of which
      are
      hereby acknowledged, the parties agree as follows:

    

    
      	 	
              1.

            	
              AGREEMENT
                TO PURCHASE; PURCHASE
                PRICE

            

    

     

    (a) Purchase
      of Preferred Stock and the Warrants.
      Subject
      to the terms and conditions in this Agreement, the Purchaser hereby agrees
      to
      purchase from the Company, and the Company hereby agrees to issue and sell
      to
      the Purchaser up to 833,334 shares of Series E Preferred Stock and Warrants
      to
      purchase up to 833,334 shares of Common Stock based on a ratio of one (1)
      Warrant share for each Series E Preferred Stock share issued. The aggregate
      maximum purchase price for the Series E Preferred Stock shall be $5,000,000
      ($6.00 per share of Series E Preferred Stock), which shall be payable in
      immediately available funds on the applicable closing dates as determined
      pursuant to Section 1(b) below. With respect to the Warrants (i) 416,667 shall
      have an exercise price of $.001 per share of Common Stock, and (ii) 416,667
      shall have an exercise price of $4.00 per share of Common Stock. The Warrants
      shall be in the form of Exhibit B attached hereto.

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    (b) Closings.
      Delivery of the shares of Series E Preferred Stock to be purchased by the
      Purchaser hereunder shall be made in the form of one or more stock certificates,
      registered in such names as the Purchaser may specify and in each case dated
      as
      of each Closing Date (as defined below). Delivery of all Warrants to be
      purchased by the Purchaser hereunder shall be made in the form of one or more
      Warrants, registered in such names as specified in Schedule A hereto (based
      on
      the allocation set forth therein) at the time of the initial Closing Date.
      Payment of the aggregate purchase price for such shares of Series E Preferred
      Stock shall be made by the Purchaser in the form specifically agreed by the
      parties or by wire transfer to an account of the Company, by 5:00 PM, Eastern
      Standard Time, on the applicable closing date, and any such closing date being
      referred to herein as a “Closing
      Date.”
      Closings shall occur as and when agreed by the parties in order to finance
      the
      Company’s needs for working capital. The Company shall submit each sale request
      (a “Request”)
      to
      Purchaser at least two weeks before the desired Closing Date. In connection
      with
      each Request, the Company shall state the number of shares of Series E Preferred
      Stock to be sold, in increments of 50,000 shares, and shall provide to Purchaser
      the proposed use of proceeds, together with such information regarding the
      Company’s business and financial condition as Purchaser shall request. Purchaser
      shall have the right to accept or reject any Request in its sole discretion;
      provided, however, that the Purchaser shall not be permitted to reject Requests
      to sell up to an aggregate of 500,000 shares of Series E Preferred Stock after
      the initial Closing Date provided that the Company is in compliance with this
      Agreement in all material respects as of each relevant Request Date and Closing
      Date.

     

    (c) Initial
      Closing.
      The
      initial Closing Date shall occur promptly following the execution of this
      Agreement. At such time, the Company shall deliver all of the Warrants purchased
      hereunder registered in such names as specified in Schedule A attached hereto.
      

     

    (d) Purchaser’s
      Option. Notwithstanding
      any provision of this Agreement to the contrary, Purchaser may, at any time
      with
      two years from the date of this Agreement, require the Company to sell to
      Purchaser, consistent with Sections 1(a) and (b) above, shares of Series E
      Preferred Stock remaining available hereunder in increments of 50,000 shares
      on
      two weeks prior written notice to the Company.

     

    
      	 	
              2.

            	
              REPRESENTATIONS
                AND WARRANTIES OF THE PURCHASER; ACCESS TO INFORMATION; INDEPENDENT
                INVESTIGATION

            

    

     

    The
      Purchaser represents and warrants to, and covenants and agrees with, the Company
      as follows:

    

    (a) Qualified
      Investor.
      The
      Purchaser is (i) experienced in making investments of the kind described in
      this
      Agreement and the related documents, (ii) able to afford the entire loss of
      its
      investment in the Series E Preferred Stock and the Warrants, and (iv) an
“Accredited
      Investor”
as
      defined in Rule 501(a) of Regulation D and knows of no reason to anticipate
      any
      material change in its financial condition for the foreseeable
      future.

     

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

     

    (b) Speculative
      Nature of Investment.
      The
      Purchaser understands and acknowledges that an investment in the Company is
      highly speculative and involves substantial risks. The Purchaser can bear the
      economic risk of the Purchaser’s investment and is able, without impairing the
      Purchaser’s financial condition, to hold the Series E Preferred Stock and the
      Warrants for an indefinite period of time and to suffer a complete loss of
      such
      Purchaser’s investment. 

     

    (c) Restricted
      Securities.
      The
      securities are “restricted securities” as defined in Rule 144 promulgated under
      the Securities Act. All subsequent offers and sales by the Purchaser of the
      Note, the Series E Preferred Stock and the Warrants and the Common Stock
      issuable upon conversion of the Series E Preferred Stock or exercise of the
      Warrants shall be made pursuant to an effective registration statement under
      the
      Securities Act or pursuant to an applicable exemption from such registration.
      

     

    (d) Reliance
      on Representations.
      The
      Purchaser understands that the Series E Preferred Stock and the Warrants are
      being offered and sold to it in reliance upon exemptions from the registration
      requirements of the United States federal securities laws, and that the Company
      is relying upon the truthfulness and accuracy of the Purchaser’s representations
      and warranties, and the Purchaser’s compliance with its covenants and
      agreements, each as set forth herein, in order to determine the availability
      of
      such exemptions and the eligibility of the Purchaser to acquire the Series
      E
      Preferred Stock and the Warrants. 

     

    (e) Access
      to Information.
      The
      Purchaser (i) has been provided with sufficient information with respect to
      the
      business of the Company for the Purchaser to determine the suitability of making
      an investment in the Company and such documents relating to the Company as
      the
      Purchaser has requested and the Purchaser has carefully reviewed the same,
      (ii)
      has been provided with such additional information with respect to the Company
      and its business and financial condition as the Purchaser, or the Purchaser’s
      agent or attorney, has requested, and (iii) has had access to management of
      the
      Company and the opportunity to discuss the information provided by management
      of
      the Company and any questions that the Purchaser had with respect thereto have
      been answered to the full satisfaction of the Purchaser. 

     

    (f) Legality.
      The
      Purchaser has the requisite corporate power and authority to enter into this
      Agreement. 

     

    (g) Authorization.
      This
      Agreement and any related agreements, and the transactions contemplated hereby
      and thereby, have been duly and validly authorized by the Purchaser, and such
      agreements, when executed and delivered by each of the Purchaser and the Company
      will each be a valid and binding agreement of the Purchaser, enforceable in
      accordance with their respective terms, except to the extent that enforcement
      of
      each such agreement may be limited by bankruptcy, insolvency, reorganization,
      moratorium, fraudulent conveyance or other similar laws now or hereafter in
      effect relating to creditors rights generally and to general principles of
      equity.

     

    
      
         

      

      
        3

        
          

        

      

      
         

      

    

     

    (h) Adequate
      Resources.
      The
      Purchaser, or an affiliate of the Purchaser, has sufficient liquid assets to
      deliver the aggregate purchase price during the term of the
      Agreement.

     

    (i) Investment.
      The
      Purchaser is acquiring the Series E Preferred Stock and the Warrants for
      investment for the Purchaser’s own account, not as a nominee or agent, and not
      with the view to, or for resale in connection with, any distribution thereof,
      nor with any present intention of distributing or selling such Series E
      Preferred Stock or Warrants. The Purchaser is aware of the limits on resale
      imposed by virtue of the transaction contemplated by this Agreement and is
      aware
      that the Series E Preferred Stock and the Warrants will bear restrictive
      legends.

     

    (j) Litigation.
      There
      is no action, suit, proceeding or investigation pending or, to the Knowledge
      of
      the Purchaser (as defined herein), currently threatened against the Purchaser
      that questions the validity of the Primary Documents (as defined below) or
      the
      right of Purchaser to enter into any such agreements or to consummate the
      transactions contemplated hereby and thereby, nor, to the Knowledge of
      Purchaser, is there any basis for the foregoing. All references to the
“Knowledge”
means
      the actual knowledge of the person in question or the knowledge such person
      could reasonably be expected to have each after reasonable investigation and
      due
      diligence.

     

    (k) Tax
      Advisors.
      The
      Purchaser has reviewed with its own tax advisors the U.S. federal, state, local
      and foreign tax consequences of this investment and the transactions
      contemplated by the Primary Documents. With respect to such matters, the
      Purchaser relies solely on such advisors and not on any statements or
      representations of the Company or any of its agents, written or oral. The
      Purchaser understands that it (and not the Company) shall be responsible for
      its
      own tax liability that may arise as a result of this investment or the
      transactions contemplated by the Primary Documents.

     

    (l) Broker’s
      Fees and Commissions.
      Neither
      the Purchaser nor any of its officers, partners, employees or agents has
      employed any investment banker, broker, or finder in connection with the
      transactions contemplated by the Primary Documents. 

     

    
      	 	
              3.

            	
              REPRESENTATIONS
                OF THE COMPANY 

            

    

     

    The
      Company represents and warrants to, and covenants and agrees with, the Purchaser
      that:

    

    (a) Organization.
      The
      Company is a corporation duly organized and validly existing and in good
      standing under the laws of the State of Nevada and has all requisite corporate
      power and authority to carry on its business as now conducted. The Company
      is
      duly qualified as a foreign corporation and in good standing in all
      jurisdictions in which either the ownership or use of the properties owned
      or
      used by it, or the nature of the activities conducted by it, requires such
      qualification. The minute books and stock record books and other similar records
      of the Company have been made available to the Purchaser or its counsel prior
      to
      the execution of this Agreement, are complete and correct in all material
      respects and have been maintained in accordance with sound business practices.
      Such minute books contain true and complete records of all actions taken at
      all
      meetings and by all written consents in lieu of meetings of the directors,
      stockholders and committees of the board of directors of the Company from the
      date of organization through the date hereof. The Company has, prior to the
      execution of this Agreement, delivered to the Purchaser true and complete copies
      of the Company’s Articles of Incorporation, and Bylaws, each as amended through
      the date hereof. The Company is not in violation of any provisions of its
      Articles of Incorporation or Bylaws. 

     

    
      
         

      

      
        4

        
          

        

      

      
         

      

    

     

    (b) Capitalization.
      Capitalization.
      On the
      date hereof, the authorized capital of the Company consists of:
      (i) 150,000,000 shares of Common Stock, par value $0.001 per share, of
      which 7,408,846 shares are issued and outstanding and (ii) 15,000,000
      shares of preferred stock, par value $0.001 per share, of which 4,625,000 shares
      of Series C Preferred Stock are issued and outstanding, 1,425,000 shares of
      Series D Preferred Stock are issued and outstanding and - 0 - shares of Series
      E
      Preferred Stock are outstanding. The Company’s filings with the Commission (the
“Commission
      Filings”)
      accurately disclose the outstanding capital stock of the Company and all
      outstanding options, warrants, notes, or any other rights or instruments which
      would entitle the holder thereof to acquire shares of the Common Stock or other
      equity interests in the Company upon conversion or exercise, setting forth
      for
      each such holder the type of security, number of equity shares covered
      thereunder, the exercise or conversion price thereof, the vesting schedule
      thereof (if any), and the issuance date and expiration date thereof. Other
      than
      as disclosed in the Commission Filings, there are no outstanding rights,
      agreements, arrangements or understandings to which the Company is a party
      (written or oral) which would obligate the Company to issue any equity interest,
      option, warrant, convertible note, or other types of securities or to register
      any shares in a registration statement filed with the Commission. Other than
      as
      disclosed in the Commission Filings, there is no agreement, arrangement or
      understanding between or among any entities or individuals which affects,
      restricts or relates to voting, giving of written consents, dividend rights
      or
      transferability of shares with respect to any voting shares of the Company,
      including without limitation any voting trust agreement or proxy. The Commission
      Filings accurately disclose all the shares subject to “lock-up” or similar
      agreements or arrangements by which any equity shares are subject to resale
      restrictions and the Company has provided the Purchaser complete and accurate
      copies of all such agreements, which agreements are in full force and effect.
      Except as set forth in the Commission Filings, there are no outstanding
      obligations of the Company to repurchase, redeem or otherwise acquire for value
      any outstanding shares of capital stock or other ownership interests of the
      Company or to provide funds to or make any investment (in the form of a loan,
      capital contribution or otherwise) in any other entity. There are no
      anti-dilution or price adjustment provisions regarding any security issued
      by
      the Company (or in any agreement providing rights to security holders) that
      will
      be triggered by the issuance of the Securities (as defined below). 

     

    (c) Concerning
      the Common Stock, the Preferred Stock and the Warrants.
      The
      Series E Preferred Stock, the Warrants and the Common Stock issuable upon
      conversion of the Series E Preferred Stock and upon exercise of the Warrants
      when issued, shall be duly and validly issued, fully paid and non-assessable
      and
      will not subject the holder thereof to personal liability by reason of being
      such a holder. 

     

    (d) Authorized
      Shares.
      The
      Company shall have available a sufficient number of authorized and unissued
      shares of Common Stock as may be necessary to effect conversion of the Series
      E
      Preferred Stock and the exercise of the Warrants. The Company understands and
      acknowledges the potentially dilutive effect to the Common Stock of the issuance
      of shares of Common Stock upon the conversion of the Series E Preferred Stock
      and the exercise of the Warrants. The Company further acknowledges that its
      obligation to issue shares of Common Stock upon conversion of the Series E
      Preferred Stock and upon exercise of the Warrants is absolute and unconditional
      regardless of the dilutive effect that such issuance may have on the ownership
      interests of other stockholders of the Company. 

     

    
      
         

      

      
        5

        
          

        

      

      
         

      

    

     

    (e) Authorization;
      Enforcement.
      This
      Agreement, the Warrants, the Registration Rights Agreement Amendment (as defined
      below) and the Series E Certificate of Designation (collectively, the
“Primary
      Documents”),
      and
      the transactions contemplated hereby and thereby, have been duly and validly
      authorized by the Company; this Agreement has been duly executed and delivered
      by the Company and this Agreement is, and the other Primary Documents, when
      executed and delivered by the Company, will each be, a valid and binding
      agreement of the Company, enforceable in accordance with their respective terms,
      except to the extent that enforcement of each of the Primary Documents may
      be
      limited by bankruptcy, insolvency, reorganization, moratorium, fraudulent
      conveyance or other similar laws now or hereafter in effect relating to
      creditors’ rights generally and to general principles of equity. 

     

    (f) Financial
      Statements.
      The
      financial statements and related notes thereto contained in the Company’s
      filings with the Commission (the “Company
      Financials”)
      are
      correct and complete in all material respects, comply in all material respects
      with the Securities Exchange Act of 1934, as amended (the “Exchange
      Act”),
      and
      the rules and regulations of the Commission promulgated thereunder and have
      been
      prepared in accordance with United States generally accepted accounting
      principles applied on a basis consistent throughout the periods indicated and
      consistent with each other. The Company Financials present fairly and accurately
      the financial condition and operating results of the Company in all material
      respects as of the dates and during the periods indicated therein and are
      consistent with the books and records of the Company. Except as set forth in
      the
      Company Financials, the Company has no material liabilities, contingent or
      otherwise, other than liabilities disclosed on the balance sheet as of
      June 30, 2008. Since
      January 1, 2008, there has been no change in any accounting policies,
      principles, methods or practices, including any change with respect to reserves
      (whether for bad debts, contingent liabilities or otherwise), of the Company.
      

     

    (g) Commission
      Filings.
      The
      Company has made all filings with the Commission that it has been required
      to
      make under the Securities Act and the Exchange Act and has furnished or made
      available to the Purchaser true and complete copies of all the documents it
      has
      filed with the Commission since its inception, all in the forms so filed. As
      of
      their respective filing dates, such filings already filed by the Company or
      to
      be filed by the Company after the date hereof but before the initial Closing
      Date complied or, if filed after the date hereof, will comply in all material
      respects with the requirements of the Securities Act and the Exchange Act,
      and
      the rules and regulations of the Commission promulgated thereunder, as the
      case
      may be, and none of the filings with the Commission contained or will contain
      any untrue statement of a material fact or omitted or will omit any material
      fact required to be stated therein or necessary to make the statements made
      therein, in light of the circumstances in which they were made, not misleading,
      except to the extent such filings have been all prior to the date of this
      Agreement corrected, updated or superseded by a document subsequently filed
      with
      Commission.

     

    
      
         

      

      
        6

        
          

        

      

      
         

      

    

     

    (h) Non-Contravention.
      The
      execution and delivery of this Agreement and each of the other Primary
      Documents, and the consummation by the Company of the transactions contemplated
      by this Agreement and each of the other Primary Documents, do not and will
      not
      conflict with, or result in a breach by the Company of, or give any third party
      any right of termination, cancellation, acceleration or modification in or
      with
      respect to, any of the terms or provisions of, or constitute a default under,
      (A) its Articles of Incorporation or Bylaws, as amended through the date hereof,
      (B) any material indenture, mortgage, deed of trust, lease or other agreement
      or
      instrument to which the Company is a party or by which it or any of its
      properties or assets are bound, or (C) any existing applicable law, rule, or
      regulation or any applicable decree, judgment or order of any court or federal,
      state, securities industry or foreign regulatory body, administrative agency,
      or
      any other governmental body having jurisdiction over the Company or any of
      their
      properties or assets (collectively, “Legal
      Requirements”),
      other
      than those which have been waived or satisfied on or prior to the initial
      Closing Date. 

     

    (i) Approvals
      and Filings.
      Other
      than the completion of the filing of the Series E Certificate of Designation,
      no
      authorization, approval or consent of any court, governmental body, regulatory
      agency, self-regulatory organization, stock exchange or market or the
      stockholders of the Company is required to be obtained by the Company for the
      entry into or the performance of this Agreement and the other Primary Documents.
      

     

    (j) Compliance
      With Legal Requirements.
      Except
      as disclosed in the Commission Filings, the Company has not violated in any
      material respect, and is not currently in material default under, any Legal
      Requirement applicable to the Company, or any of the assets or properties of
      the
      Company, where such violation could reasonably be expected to have material
      adverse effect on the business or financial condition of the
      Company. 

     

    (k) Absence
      of Certain Changes.
      Since
      January 1, 2008, except as previously disclosed in the Commission Filings,
      there
      has been no material adverse change nor any material adverse development in
      the
      business, properties, operations, financial condition, prospects, outstanding
      securities or results of operations of the Company, and no event has occurred
      or
      circumstance exists that may result in such a material adverse
      change. 

     

    (l) Indebtedness
      to Officers, Directors and Stockholders.
      The
      Company is not indebted to any of the Company’s stockholders, officers or
      directors or their Affiliates in any amount whatsoever (including, without
      limitation, any deferred compensation, salaries or rent payable). 

     

    
      
         

      

      
        7

        
          

        

      

      
         

      

    

     

    (m) Relationships
      with Related Persons.
      Except
      as disclosed in the Commission Filings, no officer, director, or principal
      stockholder of the Company nor any Related Person (as defined below) of any
      of
      the foregoing has, or since December 31, 2007, has had, any interest in any
      property (whether real, personal, or mixed and whether tangible or intangible)
      used in or pertaining to the business of the Company. Except disclosed in the
      Commission Filings, no officer, director, or principal stockholder of the
      Company nor any Related Person of the any of the foregoing is, or since December
      31, 2007, has owned an equity interest or any other financial or profit interest
      in, a Person (as defined below) that has (i) had business dealings or a material
      financial interest in any transaction with the Company, or (ii) engaged in
      competition with the Company with respect to any line of the merchandise or
      services of such company (a “Competing
      Business”)
      in any
      market presently served by such company except for ownership of less than one
      percent of the outstanding capital stock of any Competing Business that is
      publicly traded on any recognized exchange or in the over-the-counter market.
      Except as disclosed in the Commission Filings, no director, officer, or
      principal stockholder of the Company nor any Related Person of any of the
      foregoing is a party to any Contract with, or has claim or right against, the
      Company. As used in this Agreement, “Person”
means
      any individual, corporation (including any non-profit corporation), general
      or
      limited partnership, limited liability company, joint venture, estate, trust,
      association, organization, labor union, or other entity or any governmental
      body; “Related
      Person”
means,
      (X) with respect to a particular individual, (a) each other member of such
      individual’s Family (as defined below); (b) any Person that is directly or
      indirectly controlled by such individual or one or more members of such
      individual’s Family; (c) any Person in which such individual or members of such
      individual’s Family hold (individually or in the aggregate) a Material Interest
      (as defined below); and (d) any Person with respect to which such individual
      or
      one or more members of such individual’s Family serves as a director, officer,
      partner, executor, or trustee (or in a similar capacity); (Y) with respect
      to a
      specified Person other than an individual, (a) any Person that directly or
      indirectly controls, is directly or indirectly controlled by, or is directly
      or
      indirectly under common control with such specified Person; (b) any Person
      that
      holds a Material Interest in such specified Person; (c) each Person that serves
      as a director, officer, partner, executor, or trustee of such specified Person
      (or in a similar capacity); (d) any Person in which such specified Person holds
      a Material Interest; (e) any Person with respect to which such specified Person
      serves as a general partner or a trustee (or in a similar capacity); and (f)
      any
      Related Person of any individual described in clause (b) or (c). For purposes
      of
      the foregoing definition, (a) the “Family”
of
      an
      individual includes (i) the individual, (ii) the individual’s spouse and former
      spouses, (iii) any other natural person who is related to the individual or
      the
      individual’s spouse within the second degree, and (iv) any other natural person
      who resides with such individual, and (b) “Material
      Interest”
means
      direct or indirect beneficial ownership (as defined in Rule 13d-3 under the
      Exchange Act) of voting securities or other voting interests representing at
      least 1% of the outstanding voting power of a Person or equity securities or
      other equity interests representing at least 1% of the outstanding equity
      securities or equity securities in a Person. 

     

    (n) Title
      to Properties; Liens and Encumbrances.
      The
      Company has good and marketable title to all of its material properties and
      assets, both real and personal, and has good title to all its leasehold
      interests. Except as disclosed in the Commission Filings, all material
      properties and assets reflected in the Company Financials are free and clear
      of
      all Encumbrances (as defined below) except liens for current Taxes not yet
      due.
      As used in this Agreement, “Encumbrance”
means
      any charge, claim, community property interest, condition, equitable interest,
      lien, pledge, security interest, right of first refusal, or restriction of
      any
      kind, including any restriction on use, voting, transfer, receipt of income,
      or
      exercise of any other attribute of ownership. 

     

    (o) Permits.
      The
      Company has all permits, licenses and any similar authority necessary for the
      conduct of its business as now conducted, the lack of which would materially
      and
      adversely affect the business or financial condition of such company. The
      Company is not in default in any respect under any of such permits, licenses
      or
      similar authority. 

     

    
      
         

      

      
        8

        
          

        

      

      
         

      

    

     

    (p) Absence
      of Litigation.
      There
      is no action, suit, proceeding, inquiry or investigation before or by any court,
      public board or body, or arbitration tribunal pending or, to the Knowledge
      of
      the Company, threatened, against or affecting the Company, in which an
      unfavorable decision, ruling or finding would have a material adverse effect
      on
      the properties, business, condition (financial or other) or results of
      operations of the Company, taken as a whole, or the transactions contemplated
      by
      the Primary Documents, or which would adversely affect the validity or
      enforceability of, or the authority or ability of the Company to perform its
      obligations under, the Primary Documents.
      All
      references to the “Knowledge
      of the Company”
in
      this
      Agreement shall mean the actual knowledge of the Company or the knowledge that
      the Company could reasonably be expected to have, after reasonable investigation
      and due diligence.

     

    (q) No
      Default.
      The
      Company is not in default in the performance or observance of any obligation,
      covenant or condition contained in any indenture, mortgage, deed of trust or
      other instrument or agreement to which it is a party or by which it or its
      property may be bound. 

     

    (r) Taxes.

     

    (i) All
      Tax
      Returns (as defined below) required to have been filed by or with respect to
      the
      Company (including any extensions) have been filed. All such Tax Returns are
      true, complete and correct in all material respects. All Taxes (as defined
      below) due and payable by the Company, whether or not shown on any Tax Return,
      or claimed to be due by any Taxing Authority (as defined below), have been
      paid
      or accrued on the balance sheet included in the Company’s latest filing with the
      Commission. 

     

    (ii) The
      Company does not have any material liability for Taxes outstanding other than
      as
      reflected in the balance sheet included in the Company’s latest filing with the
      Commission or incurred subsequent to the date of such filing in the ordinary
      course of business. The unpaid Taxes of the Company (i) did not, as of the
      most
      recent fiscal month end, exceed by any material amount the reserve for liability
      for income tax (other than the reserve for deferred taxes established to reflect
      timing differences between book and tax income) set forth on the face of the
      balance sheet included in the Company’s latest filing with the Commission, and
      (ii) will not exceed by any material amount that reserve as adjusted for
      operations and transactions through the initial Closing Date. 

     

    (iii) The
      Company is not a party to any agreement extending the time within which to
      file
      any Tax Return. No claim has ever been made by a Taxing Authority of any
      jurisdiction in which the Company does not file Tax Returns that the Company
      is
      or may be subject to taxation by that jurisdiction. 

     

    (iv) The
      Company has withheld and paid all Taxes required to have been withheld and
      paid
      in connection with amounts paid or owing to any employee, creditor or
      independent contractor. 

     

    (v) There
      has
      been no action by any Taxing Authority in connection with assessing additional
      Taxes against, or in respect of, the Company for any past period. There is
      no
      dispute or claim concerning any Tax liability of the Company either (i) claimed,
      raised or, to the Knowledge of the Company, threatened by any Taxing Authority
      or (ii) of which the Company is otherwise aware. There are no liens for Taxes
      upon the assets and properties of the Company other than liens for Taxes not
      yet
      due. None of the Tax Returns of the Company have been audited or examined by
      Taxing Authorities, and none of the Tax Returns of the Company currently are
      the
      subject of audit or examination. The Company has made available to the Purchaser
      complete and correct copies of all federal, state, local and foreign income
      Tax
      Returns filed by, and all Tax examination reports and statements of deficiencies
      assessed against or agreed to by, the Company since the fiscal year ended
      December 31, 2005.

     

    
      
         

      

      
        9

        
          

        

      

      
         

      

    

     

    (vi) There
      are
      no outstanding agreements or waivers extending the statutory period of
      limitation applicable to any Tax Returns required to be filed by, or which
      include or are treated as including, the Company or with respect to any Tax
      assessment or deficiency affecting the Company.

     

    (vii) The
      Company has not received any written ruling related to Taxes or entered into
      any
      agreement with a Taxing Authority relating to Taxes.

     

    (viii) Except
      as
      included in the Company’s latest filing with the Commission, the Company does
      not have any liability for the Taxes of any person or entity other than the
      Company (i) under Section 1.1502-6 of the Treasury regulations (or any similar
      provision of state, local or foreign Legal Requirements), (ii) as a transferee
      or successor, (iii) by contract or (iv) otherwise. 

     

    (ix) The
      Company (i) has not agreed to make nor is required to make any adjustment under
      Section 481 of the Internal Revenue Code by reason of a change in accounting
      method and (ii) is not a “consenting corporation” within the meaning of Section
      341(f)(1) of the Internal Revenue Code. 

     

    (x) The
      Company is not a party to or bound by any obligations under any tax sharing,
      tax
      allocation, tax indemnity or similar agreement or arrangement. 

     

    (xi) The
      Company is not involved in, subject to, or a party to any joint venture,
      partnership, contract or other arrangement that is treated as a partnership
      for
      federal, state, local or foreign Tax purposes. 

     

    (xii) The
      Company was not included nor is includible, in the Tax Return of any other
      entity.

     

    As
      used
      in this Agreement, a “Tax
      Return”
means
      any return, report, information return, schedule, certificate, statement or
      other document (including any related or supporting information) filed or
      required to be filed with, or, where none is required to be filed with a Taxing
      Authority, the statement or other document issued by, a Taxing Authority in
      connection with any Tax; “Tax”
means
      any and all taxes, charges, fees, levies or other assessments, including,
      without limitation, income, gross, receipts, excise, real or personal property,
      sales, withholding, social security, retirement, unemployment, occupation,
      use,
      service, service use, license, net worth, payroll, franchise, transfer and
      recording taxes, fees and charges, imposed by Taxing Authority, whether computed
      on a separate, consolidated, unitary, combined or any other basis; and such
      term
      includes any interest whether paid or received, fines, penalties or additional
      amounts attributable to, or imposed upon, or with respect to, any such taxes,
      charges, fees, levies or other assessments; and “Taxing
      Authority”
means
      any governmental agency, board, bureau, body, department or authority of any
      United States federal, state or local jurisdiction or any foreign jurisdiction,
      having or purporting to exercise jurisdiction with respect to any
      Tax.

    
      
         

      

      
        10

        
          

        

      

      
         

      

    

     

    (s) Certain
      Prohibited Activities.
      Neither
      the Company nor any of its directors, officers or other employees has (i) used
      any Company funds for any unlawful contribution, endorsement, gift,
      entertainment or other unlawful expense relating to any political activity,
      (ii)
      made any direct or indirect unlawful payment of Company funds to any foreign
      or
      domestic government official or employee, (iii) violated or is in violation
      of
      any provision of the Foreign Corrupt Practices Act of 1977, as amended, or
      (iv)
      made any bribe, rebate, payoff, influence payment, kickback or other similar
      payment to any person.

     

    (u) Agent
      Fees.
      The
      Company has not incurred any liability for any finder’s or brokerage fees or
      agent’s commissions in connection with the transactions contemplated by this
      Agreement.

     

    (v) Private
      Offering.
      Subject
      to the accuracy of the Purchaser’s representations and warranties set forth in
      Section 2
      hereof,
      (i) the offer, sale and issuance of the Series E Preferred Stock and the
      Warrants, (ii) the issuance of Common Stock pursuant to the conversion and/or
      exercise of such securities into shares of Common Stock, each as contemplated
      by
      the Primary Documents, are exempt from the registration requirements of the
      Securities Act. The Company agrees that neither the Company nor anyone acting
      on
      its behalf will offer any of the Series E Preferred Stock, the Warrants or
      any
      similar securities for issuance or sale, or solicit any offer to acquire any
      of
      the same from anyone so as to render the issuance and sale of such securities
      subject to the registration requirements of the Securities Act. The Company
      has
      not offered or sold the Series E Preferred Stock or the Warrants by any form
      of
      general solicitation or general advertising, as such terms are used in Rule
      502(c) under the Securities Act.

     

    
      	 	
              4.

            	
              CERTAIN
                COVENANTS, ACKNOWLEDGMENTS AND
                RESTRICTIONS

            

    

     

    (a) Termination
      of Convertible Debenture Purchase Agreement.
      The
      parties acknowledge and agree that the Convertible Debenture Purchase Agreement,
      dated as of August 17, 2007, as amended on March 27, 2008, by and between the
      parties is hereby terminated and cancelled with no further force or effect.
      Without limiting the generality of the foregoing, the Company shall not be
      required to sell or issue any Debentures to the Purchaser thereunder.
      Notwithstanding the foregoing, all warrants previously issued to the Purchaser
      and its assigns in connection with the Convertible Debenture Purchase Agreement
      shall remain outstanding and shall not be cancelled as a result of the
      termination of the Convertible Debenture Purchase Agreement.

     

    (b) Transfer
      Restrictions.
      The
      Purchaser acknowledges that (i) neither the Series E Preferred Stock, the
      Warrants nor the Common Stock issuable upon conversion of the Series E Preferred
      Stock or upon exercise of the Warrants have been registered under the Securities
      Act, and such securities may not be transferred unless (A) subsequently
      registered thereunder or (B) they are transferred pursuant to an exemption
      from
      such registration, and (ii) any sale of the Series E Preferred Stock, the
      Warrants or the Common Stock issuable upon conversion, exercise or exchange
      thereof (collectively, the “Securities”)
      made
      in reliance upon Rule 144 under the Securities Act (“Rule
      144”)
      may be
      made only in accordance with the terms of said Rule 144. The provisions of
      Section 4(b) and 4(d) hereof, together with the rights of the Purchaser under
      this Agreement and the other Primary Documents, shall be binding upon any
      subsequent transferee of the Series E Preferred Stock and the
      Warrants. 

     

    
      
         

      

      
        11

        
          

        

      

      
         

      

    

     

    (c) Restrictive
      Legend.
      The
      Purchaser acknowledges and agrees that, until such time as the Securities shall
      have been registered under the Securities Act or the Purchaser demonstrates
      to
      the reasonable satisfaction of the Company and its counsel that such
      registration shall no longer be required, such Securities may be subject to
      a
      stop-transfer order placed against the transfer of such Securities, and such
      Securities shall bear a restrictive legend in substantially the following
      form:

     

    THESE
      SECURITIES (INCLUDING ANY UNDERLYING SECURITIES) HAVE NOT BEEN REGISTERED UNDER
      THE SECURITIES ACT OF 1933, AS AMENDED. THEY MAY NOT BE SOLD, OFFERED FOR SALE,
      PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED IN THE ABSENCE OF AN EFFECTIVE
      REGISTRATION STATEMENT AS TO THE SECURITIES UNDER SAID ACT OR AN OPINION OF
      COUNSEL OR OTHER EVIDENCE REASONABLY SATISFACTORY TO THE COMPANY THAT SUCH
      REGISTRATION SHALL NO LONGER BE REQUIRED.

    

    (d) Filings.
      The
      Company undertakes and agrees that it will make all required filings in
      connection with the sale of the Securities to the Purchaser as required by
      federal and state laws and regulations, or by any domestic securities exchange
      or trading market, and if applicable, the filing of a notice on Form D (at
      such
      time and in such manner as required by the rules and regulations of the
      Commission), and to provide copies thereof to the Purchaser promptly after
      such
      filing or filings. With a view to making available to the holders of the
      Securities the benefits of Rule 144 and any other rule or regulation of the
      Commission that may at any time permit such holder to sell securities of the
      Company to the public without registration or pursuant to a registration on
      Form
      S-3, the Company shall (a) at all times make and keep public information
      available, as those terms are understood and defined in Rule 144, (b) file
      on a
      timely basis with the Commission all information that the Commission may require
      under either of Section 13 or Section 15(d) of the Exchange Act and, so long
      as
      it is required to file such information, take all actions that may be required
      as a condition to the availability of Rule 144 (or any successor exemptive
      rule
      hereafter in effect) with respect to the Common Stock; and (d) furnish to any
      holder of the Securities forthwith upon request (i) a written statement by
      the
      Company as to its compliance with the reporting requirements of Rule 144, (ii)
      a
      copy of the most recent annual or quarterly report of the Company as filed
      with
      the Commission, and (iii) any other reports and documents that a holder of
      the
      Securities may reasonably request in order to avail itself of any rule or
      regulation of the Commission allowing such holder to sell any such Securities
      without registration.

     

    (e) Reservation
      of Common Stock.
      The
      Company will at all times have authorized and reserved for the purpose of
      issuance a sufficient number of shares of Common Stock to provide for the
      conversion of the Series E Preferred Stock and the exercise of the
      Warrants.

     

    
      
         

      

      
        12

        
          

        

      

      
         

      

    

     

    (f) Registration
      Requirement.
      Upon
      the execution of this Agreement, the holders of the Securities and the Company
      shall execute an amendment, in the form attached hereto as Exhibit C (the
“Registration
      Rights Agreement Amendment”),
      to
      that certain Amended and Restated Registration Rights Agreement, dated July
      25,
      2008, by and between the parties hereto.

     

    (g) Return
      of Certificates on Conversion and Warrants on Exercise.
      

     

    (i) Upon
      any
      conversion by the Purchaser of less than all of the Series E Preferred Stock
      pursuant to the terms of the Series E Certificate of Designation, the Company
      shall issue and deliver to the Purchaser, within seven business days of the
      date
      of conversion, a new certificate or certificates for, as applicable, the total
      number of shares of the Series E Preferred Stock, which the Purchaser has not
      yet elected to convert (with the number of and denomination of such new
      certificate(s) designated by the Purchaser).

     

    (ii) Upon
      any
      partial exercise by the Purchaser of the Warrants, the Company shall issue
      and
      deliver to the Purchaser, within seven business days of the date on which the
      Warrants is exercised, new Warrants representing the number of adjusted shares
      of Common Stock covered thereby, in accordance with the terms
      thereof.

     

    (h) Replacement
      Certificates and Warrants.
      

     

    (i) The
      certificate(s) representing the shares of the Series E Preferred Stock held
      by
      the Purchaser shall be exchangeable, at the option of the Purchaser at any
      time
      and from time to time at the office of Company, for certificates with different
      denominations representing, as applicable, an equal aggregate number of shares
      of the Series E Preferred Stock as requested by the Purchaser upon surrendering
      the same. No service charge will be made for such registration or transfer
      or
      exchange. 

     

    (ii) The
      Warrants will be exchangeable, at the option of the Purchaser, at any time
      and
      from time to time at the office of the Company, for other Warrants of different
      denominations entitling the holder thereof to purchase in the aggregate the
      same
      number of shares of Common Stock as are purchasable under such Warrants. No
      service charge will be made for such transfer or exchange.

     

    
      	 	
              5.

            	
              CONDITIONS
                TO THE COMPANY’S OBLIGATION TO ISSUE THE SHARES AND THE
                WARRANTS

            

    

     

    The
      Purchaser understands that the Company’s obligation to issue the Series E
      Preferred Stock on each Closing Date and the Warrants on the initial Closing
      Date to the Purchaser pursuant to this Agreement is conditioned upon the
      following, unless waived in writing by the Company:

    

    (a) The
      accuracy on each Closing Date of the representations and warranties of the
      Purchaser contained in this Agreement as if made on each Closing Date and the
      performance by the Purchaser on or before each Closing Date of all covenants
      and
      agreements of the Purchaser required to be performed on or before each Closing
      Date.

     

    
      
         

      

      
        13

        
          

        

      

      
         

      

    

     

    (b) The
      absence or inapplicability on each Closing Date of any and all laws, rules
      or
      regulations prohibiting or restricting the transactions contemplated hereby,
      or
      requiring any consent or approval, except for any stockholder or Board of
      Director approval or consent contemplated herein, which shall not have been
      obtained.

     

    (c) All
      regulatory approvals or filings, if any, on each Closing Date necessary to
      consummate the transactions contemplated by this Agreement shall have been
      made
      as of each Closing Date.

     

    (d) The
      receipt of good funds as of each Closing Date.

     

    
      	 	
              6.

            	
              CONDITIONS
                TO THE PURCHASER’S OBLIGATION TO PURCHASE THE SHARES AND THE
                WARRANTS

            

    

     

    The
      Company understands that the Purchaser’s obligation to purchase the Series E
      Preferred Stock on each Closing Date and the Warrants on the initial Closing
      Date pursuant to Sections 1(a) and 1(b) above is conditioned upon each of the
      following, unless waived in writing by the Purchaser:

    

    (a) The
      Purchaser shall have completed to its satisfaction its due diligence review
      of
      the Company, the Company’s business, assets and liabilities, the Company shall
      have furnished to the Purchaser and its representatives, such information as
      may
      be reasonably requested by them, and the Purchaser shall have approved the
      use
      of proceeds of the sale in its sole discretion.

     

    (b) The
      accuracy on each Closing Date of the representations and warranties of the
      Company contained in this Agreement as if made on such Closing Date, and the
      performance by the Company on or before such Closing Date of all covenants
      and
      agreements of the Company required to be performed on or before such Closing
      Date.

     

    (c) The
      Company shall have executed and delivered to the Purchaser (i) the shares of
      Series E Preferred Stock with respect to each Closing Date and (ii) all of
      the
      Warrants as of the initial Closing Date.

     

    (d) On
      each
      Closing Date, the Purchaser shall have received from the Company such other
      certificates and documents as it or its representatives, if applicable, shall
      reasonably request, and all proceedings taken by the Company or the Board of
      Directors of the Company, as applicable, in connection with the Primary
      Documents contemplated by this Agreement and the other Primary Documents and
      all
      documents and papers relating to such Primary Documents shall be satisfactory
      to
      the Purchaser.

     

    (e) All
      regulatory approvals or filings, if any, necessary to consummate the
      transactions contemplated by this Agreement shall have been made as of each
      Closing Date.

     

    
      
         

      

      
        14

        
          

        

      

      
         

      

    

     

    (f) The
      Company shall have received a Closing Certificate substantially in the form
      attached hereto as Exhibit D.

     

    (g) With
      respect to the initial Closing Date only, the Company shall have reimbursed
      the
      Purchaser the expenses incurred in connection with the negotiation or
      performance of this Agreement pursuant to Section 7
      hereof.

     

    
      	 	
              7.

            	
              FEES
                AND EXPENSES

            

    

     

    The
      Company shall bear its own costs, including attorney’s fees, incurred in the
      negotiation of this Agreement and consummating of the transactions contemplated
      herein and the corporate proceedings of the Company in contemplation hereof
      and
      thereof. At the initial Closing Date, the Company shall reimburse the Purchaser
      for all of the Purchaser’s reasonable out-of-pocket expenses incurred in
      connection with the negotiation or performance of this Agreement, including
      without limitation reasonable fees and disbursements of counsel to the
      Purchaser.

    

    
      	 	
              8.

            	
              SURVIVAL

            

    

     

    The
      agreements, covenants, representations and warranties of the Company and the
      Purchaser shall survive the execution and delivery of this Agreement and the
      delivery of the Securities hereunder for a period of two years from the date
      of
      the Final Closing Date, except that:

     

    (a) the
      Company’s representations and warranties regarding Taxes contained in Section
      3(r) of this Agreement shall survive as long as the Company remains statutorily
      liable for any obligation referenced in Section 3(r), and

     

    (b) the
      Company’s representations and warranties contained in Section 3(b)
      shall
      survive until the Purchaser and any of its affiliates are no longer holders
      of
      any of the Securities purchased hereunder.

     

    
      	 	
              9.

            	
              INDEMNIFICATION

            

    

     

    (a) Each
      of
      the Company and the Purchaser (each in such capacity under this section, the
      “Indemnifying
      Party”)
      agrees
      to indemnify the other party and each officer, director, employee, agent,
      partner, stockholder, member and affiliate of such other party (collectively,
      the “Indemnified
      Parties”)
      for,
      and hold each Indemnified Party harmless from and against: (i) any and all
      damages, losses, claims, diminution in value and other liabilities of any and
      every kind, including, without limitation, judgments and costs of settlement,
      and (ii) any and all reasonable out-of-pocket costs and expenses of any and
      every kind, including, without limitation, reasonable fees and disbursements
      of
      counsel for such Indemnified Parties (all of which expenses periodically shall
      be reimbursed as incurred), in each case, arising out of or suffered or incurred
      in connection with any of the following, whether or not involving a third party
      claim: (a) any misrepresentation or any breach of any warranty made by the
      Indemnifying Party herein or in any of the other Primary Documents, (b) any
      breach or non-fulfillment of any covenant or agreement made by the Indemnifying
      Party herein or in any of the other Primary Documents, or (c) any claim relating
      to or arising out of a violation of applicable federal or state securities
      laws
      by the Indemnifying Party in connection with the sale or issuance of the Series
      E Preferred Stock or the Warrants by the Indemnifying Party to the Indemnified
      Party (collectively, the “Indemnified
      Liabilities”).
      To
      the extent that the foregoing undertaking by the Indemnifying Party may be
      unenforceable for any reason, the Indemnifying Party shall make the maximum
      contribution to the payment and satisfaction of each of the Indemnified
      Liabilities which is permissible under applicable law.

     

    
      
         

      

      
        15

        
          

        

      

      
         

      

    

     

    No
      indemnification shall be payable in respect of any Indemnified Liability (i)
      where the claiming Indemnified Party had actual knowledge of or notice from
      information set forth in the schedules hereto of the facts giving rise to such
      Indemnified Liability prior to the initial Closing Date or (ii) where such
      Indemnified Party entered into a settlement of an Indemnified Liability without
      the prior written consent of the applicable Indemnifying Party.

     

    
      	 	
              10.

            	
              NOTICES

            

    

     

    Any
      notice required or permitted hereunder shall be given in writing (unless
      otherwise specified herein) and shall be effective upon personal delivery,
      via
      facsimile (upon receipt of confirmation of error-free transmission and mailing
      a
      copy of such confirmation, postage prepaid by certified mail, return receipt
      requested) or two business days following deposit of such notice with an
      internationally recognized courier service, with postage prepaid and addressed
      to each of the other parties thereunto entitled at the following addresses,
      or
      at such other addresses as a party may designate by five days advance written
      notice to each of the other parties hereto.

    

    
      	
              Company:

            	
              Health
                Systems Solutions, Inc.

            
	 	
              489
                Fifth Avenue, Third Floor

            
	 	
              New
                York, NY 10017

            
	 	
              Attention:
                Michael G. Levine, Chief Financial Officer

            
	 	
              Telephone:
                

            	
              212-798-9400

            
	 	
              Facsimile:

            	
              212-798-9431

            
	 	 	 
	
              with
                a copy to:

            	
              Health
                Systems Solutions, Inc.

            
	 	
              489
                Fifth Avenue, Third Floor

            
	 	
              New
                York, NY 10017

            
	 	
              Attention:
                Robert Herbst, Senior Vice President, Secretary & General
                Counsel

            
	 	
              Telephone:
                

            	
              212-798-9400

            
	 	
              Facsimile:

            	
              212-798-9431

            
	 	 	 
	 	
              -
                and -

            
	 	 	 
	 	
              Carlton
                Fields P.A.

            
	 	
              4000
                International Place

            
	 	
              100
                SE 2nd Street

            
	 	
              Miami,
                FL 33131

            
	 	
              Attention:
                Seth P. Joseph

            
	 	
              Telephone:

            	
              305-530-0050

            
	 	
              Facsimile:
                

            	
              305-530-0055

            

    

     

    
      
         

      

      
        16

        
          

        

      

      
         

      

    

    

    After
      November 1, 2008, all notices to the Company shall be delivered to the persons
      stated above at the following address: 42 West 39th
      Street,
      New York, NY 10018.

    

    
      	
              Purchaser:

            	
              Stanford
                International Bank Ltd.

            
	 	
              6075
                Poplar Avenue

            
	 	
              Memphis,
                Tennessee 38119

            
	 	
              Attention:
                James M. Davis, Chief Financial Officer

            
	 	
              Telephone:

            	
              901-680-5260

            
	 	
              Facsimile:

            	
              901-680-5265

            
	 	 	 
	
              with
                a copy to:

            	
              Stanford
                Financial Group

            
	 	
              5050
                Westheimer Road

            
	 	
              Houston,
                Texas 77056

            
	 	
              Attention:
                Mauricio Alvarado, Esq.

            
	 	
              Telephone

            	
              713-964-5145

            
	 	
              Facsimile:

            	
              713-964-5245

            

    

    

    
      	 	
              11.

            	
              GOVERNING
                LAW; JURISDICTION

            

    

     

    This
      Agreement shall be governed by and interpreted in accordance with the laws
      of
      the State of Florida, without regard to its principles of conflict of laws.
      Any
      action or proceeding seeking to enforce any provision of, or based on any right
      arising out of, this Agreement may be brought against any party in the federal
      courts of Florida or the state courts of the State of Florida, Miami-Dade County
      and each of the parties consents to the jurisdiction of such courts and hereby
      waives, to the maximum extent permitted by law, any objection, including any
      objections based on forum non conveniens, to the bringing of any such proceeding
      in such jurisdictions.

     

    
      	 	
              12.

            	
              MISCELLANEOUS

            

    

     

    (a) Entire
      Agreement. This
      Agreement supersedes all prior agreements and understandings among the parties
      hereto with respect to the subject matter hereof. This Agreement, together
      with
      the other Primary Documents, including any certificate, schedule, exhibit or
      other document delivered pursuant to their terms, constitutes the entire
      agreement among the parties hereto with respect to the subject matters hereof
      and thereof, and supersedes all prior agreements and understandings, whether
      written or oral, among the parties with respect to such subject
      matters.

     

    (b) Amendments.
      This
      Agreement may not be amended except by an instrument in writing signed by the
      party to be charged with enforcement. 

     

    (c) Waiver.
      No
      waiver
      of any provision of this Agreement shall be deemed a waiver of any other
      provisions or shall a waiver of the performance of a provision in one or more
      instances be deemed a waiver of future performance thereof.

     

    
      
         

      

      
        17

        
          

        

      

      
         

      

    

     

    (d) Construction.
      This
      Agreement and each of the Primary Documents have been entered into freely by
      each of the parties, following consultation with their respective counsel,
      and
      shall be interpreted fairly in accordance with its respective terms, without
      any
      construction in favor of or against either party. 

     

    (e) Binding
      Effect of Agreement. This
      Agreement shall inure to the benefit of, and be binding upon the successors
      and
      assigns of each of the parties hereto, including any transferees of the Series
      E
      Preferred Stock and the Warrants. 

     

    (f) Severability.
      If
      any
      provision of this Agreement shall be invalid or unenforceable in any
      jurisdiction, such invalidity or unenforceability shall not affect the validity
      or enforceability of the remainder of this Agreement or the validity or
      unenforceability of this Agreement in any other jurisdiction. 

     

    (g) Attorneys’
      Fees. If
      any
      action should arise between the parties hereto to enforce or interpret the
      provisions of this Agreement, the prevailing party in such action shall be
      reimbursed for all reasonable expenses incurred in connection with such action,
      including reasonable attorneys’ fees.

     

    (h) Headings.
      The
      headings of this Agreement are for convenience of reference only and shall
      not
      form part of, or affect the interpretation of this Agreement. 

     

    (i) Counterparts.
      This
      Agreement may be signed in one or more counterparts, each of which shall be
      deemed an original and all of which, when taken together, will be deemed to
      constitute one and the same agreement.

     

    [Signatures
      Begin on Following Page]

     

    
      
         

      

      
        18

        
          

        

      

      
         

      

    

    IN
      WITNESS WHEREOF,
      this
      Agreement has been duly executed by each of the undersigned as of the date
      first
      written above.

     

    
      	
              HEALTH
                SYSTEMS SOLUTIONS, INC.

            
	 	 
	
              By:

            	
              /s/
                Stan Vashovsky

            
	 	
              Stan
                Vashovsky

            
	 	
              Chief
                Executive Officer

            
	 	 
	
              STANFORD
                INTERNATIONAL BANK LTD.

            
	 	 
	
              By:

            	
              /s/
                James M. Davis

            
	 	
              James
                M. Davis

            
	 	
              Chief
                Financial Officer

            

    

     

    
      
         

      

      
        19

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00147-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00147-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00147-of-00352.parquet"}]]